NewslettersPancreatic Cell NewsMETTL3 Enhances Pancreatic Ductal Adenocarcinoma Progression and Gemcitabine Resistance through Modifying DDX23 mRNA N6 Adenosine MethylationBy Bob - March 29, 2023088N6-methyladenosine methyltransferase METTL3 was upregulated in PDAC tissues with gemcitabine resistance, and its knockdown sensitized pancreatic cancer cells to chemotherapy.[Cell Death & Disease]Full Article